News
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2024 financial results, positive Phase 3 ENSURE Program interim analysis. Twin Phase 3 ENSURE trials and Phase 2 CALLIPER trial on track. Webcast held on Nov 7. IMUX stock update -
-
COMMUNIQUÉ DE PRESSE
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q3 revenue of $1.9B, net income of $13M, and EPS of $0.03. Initiates Phase 3 trials for mRNA vaccines, reiterates 2024 sales guidance. Announces expansion of Executive Committee -
-
COMMUNIQUÉ DE PRESSE
Rural Regional School District Achieves Significant Increase in State Science Test Scores With New KnowAtom Curriculum
Fisher Hill Elementary School in Orange, Massachusetts sees a 26-point increase in science proficiency, thanks to KnowAtom's hands-on NGSS-based curriculum. Students engineer thermal protection systems to improve test scores -
-
COMMUNIQUÉ DE PRESSE
DealFlow Events Appoints Investor Relations Pioneer Keith L. Lippert as Senior Advisor for its January 2025 Microcap Conference for Growth Companies
DealFlow Events appoints Keith L. Lippert as Senior Advisor for the upcoming Microcap Conference, bringing extensive experience and industry contacts to enhance the event quality -
